{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T14:47:36Z","timestamp":1696258056997},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T00:00:00Z","timestamp":1425513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1038\/hr.2015.24","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T06:54:11Z","timestamp":1425538451000},"page":"485-490","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trial"],"prefix":"10.1038","volume":"38","author":[{"given":"Tatsuya","family":"Maruhashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Noma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noritaka","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kajikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumu","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuki","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James K","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihito","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,5]]},"reference":[{"key":"BFhr201524_CR1","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1056\/NEJMcp042317","volume":"352","author":"J Abrams","year":"2005","unstructured":"Abrams J . Clinical practice. Chronic stable angina. N Engl J Med 2005; 352: 2524\u20132533.","journal-title":"N Engl J Med"},{"key":"BFhr201524_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0002-8703(99)70163-8","volume":"138","author":"Y Nakamura","year":"1999","unstructured":"Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C . Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group. Am Heart J 1999; 138: 577\u2013585.","journal-title":"Am Heart J"},{"key":"BFhr201524_CR3","first-page":"1115","volume":"343","author":"Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico","year":"1994","unstructured":"Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet 1994; 343: 1115\u20131122.","journal-title":"Lancet"},{"key":"BFhr201524_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","volume":"345","author":"ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group","year":"1995","unstructured":"ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995; 345: 669\u2013685.","journal-title":"Lancet"},{"key":"BFhr201524_CR5","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1161\/01.CIR.97.20.2017","volume":"97","author":"JJ Mahmarian","year":"1998","unstructured":"Mahmarian JJ, Moye LA, Chinoy DA, Sequeira RF, Habib GB, Henry WJ, Jain A, Chaitman BR, Weng CS, Morales-Ballejo H, Pratt CM . Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized, double-blind, placebo-controlled trial. Circulation 1998; 97: 2017\u20132024.","journal-title":"Circulation"},{"key":"BFhr201524_CR6","doi-asserted-by":"publisher","first-page":"24266","DOI":"10.1074\/jbc.273.37.24266","volume":"273","author":"U Laufs","year":"1998","unstructured":"Laufs U, Liao JK . Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 1998; 273: 24266\u201324271.","journal-title":"J Biol Chem"},{"key":"BFhr201524_CR7","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1161\/01.CIR.101.17.2030","volume":"101","author":"N Sawada","year":"2000","unstructured":"Sawada N, Itoh H, Ueyama K, Yamashita J, Doi K, Chun TH, Inoue M, Masatsugu K, Saito T, Fukunaga Y, Sakaguchi S, Arai H, Ohno N, Komeda M, Nakao K . Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation 2000; 101: 2030\u20132033.","journal-title":"Circulation"},{"key":"BFhr201524_CR8","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/40187","volume":"389","author":"M Uehata","year":"1997","unstructured":"Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S . Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389: 990\u2013994.","journal-title":"Nature"},{"key":"BFhr201524_CR9","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1126\/science.275.5304.1308","volume":"275","author":"M Amano","year":"1997","unstructured":"Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsuura Y, Kaibuchi K . Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 1997; 275: 1308\u20131311.","journal-title":"Science"},{"key":"BFhr201524_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1126\/science.279.5350.509","volume":"279","author":"A Hall","year":"1998","unstructured":"Hall A . Rho GTPases and the actin cytoskeleton. Science 1998; 279: 509\u2013514.","journal-title":"Science"},{"key":"BFhr201524_CR11","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1161\/hc1002.105938","volume":"105","author":"A Masumoto","year":"2002","unstructured":"Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A . Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002; 105: 1545\u20131547.","journal-title":"Circulation"},{"key":"BFhr201524_CR12","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1161\/hy1201.096541","volume":"38","author":"A Masumoto","year":"2001","unstructured":"Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, Takeshita A . Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 2001; 38: 1307\u20131310.","journal-title":"Hypertension"},{"key":"BFhr201524_CR13","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/00005344-200211000-00013","volume":"40","author":"H Shimokawa","year":"2002","unstructured":"Shimokawa H, Hiramori K, Iinuma H, Hosoda S, Kishida H, Osada H, Katagiri T, Yamauchi K, Yui Y, Minamino T, Nakashima M, Kato K . Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovasc Pharmacol 2002; 40: 751\u2013761.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr201524_CR14","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/01.HYP.0000067062.92836.9E","volume":"41","author":"K Noma","year":"2003","unstructured":"Noma K, Higashi Y, Jitsuiki D, Hara K, Kimura M, Nakagawa K, Goto C, Oshima T, Yoshizumi M, Chayama K . Smoking activates rho-kinase in smooth muscle cells of forearm vasculature in humans. Hypertension 2003; 41: 1102\u20131105.","journal-title":"Hypertension"},{"key":"BFhr201524_CR15","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jacc.2011.05.046","volume":"58","author":"Y Kikuchi","year":"2011","unstructured":"Kikuchi Y, Yasuda S, Aizawa K, Tsuburaya R, Ito Y, Takeda M, Nakayama M, Ito K, Takahashi J, Shimokawa H . Enhanced Rho-kinase activity in circulating neutrophils of patients with vasospastic angina: a possible biomarker for diagnosis and disease activity assessment. J Am Coll Cardiol 2011; 58: 1231\u20131237.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr201524_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.atherosclerosis.2012.01.001","volume":"221","author":"MJ Hung","year":"2012","unstructured":"Hung MJ, Cherng WJ, Hung MY, Kuo LT, Cheng CW, Wang CH, Yang NI, Liao JK . Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina. Atherosclerosis 2012; 221: 521\u2013526.","journal-title":"Atherosclerosis"},{"key":"BFhr201524_CR17","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1161\/01.ATV.0000189304.32725.bd","volume":"25","author":"K Noma","year":"2005","unstructured":"Noma K, Goto C, Nishioka K, Hara K, Kimura M, Umemura T, Jitsuiki D, Nakagawa K, Oshima T, Chayama K, Yoshizumi M, Higashi Y . Smoking, endothelial function, and Rho-kinase in humans. Arterioscler Thromb Vasc Biol 2005; 25: 2630\u20132635.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr201524_CR18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jacc.2006.06.082","volume":"49","author":"K Noma","year":"2007","unstructured":"Noma K, Goto C, Nishioka K, Jitsuiki D, Umemura T, Ueda K, Kimura M, Nakagawa K, Oshima T, Chayama K, Yoshizumi M, Liao JK, Higashi Y . Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness. J Am Coll Cardiol 2007; 49: 698\u2013705.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr201524_CR19","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1161\/01.ATV.0000142813.33538.82","volume":"24","author":"S Wolfrum","year":"2004","unstructured":"Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak P, Liao JK . Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase\/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 2004; 24: 1842\u20131847.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr201524_CR20","doi-asserted-by":"publisher","first-page":"21722","DOI":"10.1074\/jbc.M000753200","volume":"275","author":"V Sauzeau","year":"2000","unstructured":"Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Smolenski A, Lohmann SM, Bertoglio J, Chardin P, Pacaud P, Loirand G . Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 2000; 275: 21722\u201321729.","journal-title":"J Biol Chem"},{"key":"BFhr201524_CR21","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.jacc.2006.12.043","volume":"49","author":"PY Liu","year":"2007","unstructured":"Liu PY, Chen JH, Lin LJ, Liao JK . Increased Rho kinase activity in a Taiwanese population with metabolic syndrome. J Am Coll Cardiol 2007; 49: 1619\u20131624.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr201524_CR22","doi-asserted-by":"publisher","first-page":"C661","DOI":"10.1152\/ajpcell.00459.2005","volume":"290","author":"K Noma","year":"2006","unstructured":"Noma K, Oyama N, Liao JK . Physiological role of ROCKs in the cardiovascular system. Am J Physiol Cell Physiol 2006; 290: C661\u2013C668.","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFhr201524_CR23","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1161\/01.RES.0000099062.55042.9A","volume":"93","author":"Z Mallat","year":"2003","unstructured":"Mallat Z, Gojova A, Sauzeau V, Brun V, Silvestre JS, Esposito B, Merval R, Groux H, Loirand G, Tedgui A . Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice. Circ Res 2003; 93: 884\u2013888.","journal-title":"Circ Res"},{"key":"BFhr201524_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/01.RES.87.3.195","volume":"87","author":"M Sato","year":"2000","unstructured":"Sato M, Tani E, Fujikawa H, Kaibuchi K . Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 2000; 87: 195\u2013200.","journal-title":"Circ Res"},{"key":"BFhr201524_CR25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/01.RES.0000096650.91688.28","volume":"93","author":"M Higashi","year":"2003","unstructured":"Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, Ichiki T, Takahashi S, Takeshita A . Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res 2003; 93: 767\u2013775.","journal-title":"Circ Res"},{"key":"BFhr201524_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.108.813311","volume":"119","author":"PY Liu","year":"2009","unstructured":"Liu PY, Liu YW, Lin LJ, Chen JH, Liao JK . Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation 2009; 119: 131\u2013138.","journal-title":"Circulation"},{"key":"BFhr201524_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/HJH.0b013e328340902d","volume":"29","author":"T Hata","year":"2011","unstructured":"Hata T, Soga J, Hidaka T, Idei N, Fujii Y, Fujimura N, Mikami S, Maruhashi T, Kihara Y, Chayama K, Kato H, Noma K, Liao JK, Higashi Y . Calcium channel blocker and Rho-associated kinase activity in patients with hypertension. J Hypertens 2011; 29: 373\u2013379.","journal-title":"J Hypertens"},{"key":"BFhr201524_CR28","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/hr.2013.60","volume":"36","author":"S Nishioka","year":"2013","unstructured":"Nishioka S, Yoshioka T, Nomura A, Kato R, Miyamura M, Okada Y, Ishizaka N, Matsumura Y, Hayashi T . Celiprolol reduces oxidative stress and attenuates left ventricular remodeling induced by hypoxic stress in mice. Hypertens Res 2013; 36: 934\u2013939.","journal-title":"Hypertens Res"},{"key":"BFhr201524_CR29","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/hr.2013.49","volume":"36","author":"M Paulo","year":"2013","unstructured":"Paulo M, Araujo AV, Bendhack LM . Sodium nitroprusside activates potassium channels in the vena cava in normotensive but not in hypertensive rats. Hypertens Res 2013; 36: 765\u2013769.","journal-title":"Hypertens Res"},{"key":"BFhr201524_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jacc.2008.04.019","volume":"52","author":"T Gori","year":"2008","unstructured":"Gori T, Parker JD . Nitrate-induced toxicity and preconditioning: a rationale for reconsidering the use of these drugs. J Am Coll Cardiol 2008; 52: 251\u2013254.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr201524_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJM198709243171304","volume":"317","author":"M Packer","year":"1987","unstructured":"Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, Yushak M . Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 1987; 317: 799\u2013804.","journal-title":"N Engl J Med"},{"key":"BFhr201524_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.atherosclerosis.2010.10.005","volume":"214","author":"T Hata","year":"2011","unstructured":"Hata T, Goto C, Soga J, Hidaka T, Fujii Y, Idei N, Fujimura N, Maruhashi T, Mikami S, Kihara Y, Chayama K, Noma K, Liao JK, Higashi Y . Measurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS\/t-MBS in comparison with vascular response to fasudil. Atherosclerosis 2011; 214: 117\u2013121.","journal-title":"Atherosclerosis"},{"key":"BFhr201524_CR33","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1161\/ATVBAHA.111.227892","volume":"31","author":"J Soga","year":"2011","unstructured":"Soga J, Noma K, Hata T, Hidaka T, Fujii Y, Idei N, Fujimura N, Mikami S, Maruhashi T, Kihara Y, Chayama K, Kato H, Liao JK, Higashi Y, Group RS . Rho-associated kinase activity, endothelial function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2011; 31: 2353\u20132359.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr201524_CR34","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/eurjhf\/hfs068","volume":"14","author":"M Dong","year":"2012","unstructured":"Dong M, Liao JK, Fang F, Lee AP, Yan BP, Liu M, Yu CM . Increased Rho kinase activity in congestive heart failure. Eur J Heart Fail 2012; 14: 965\u2013973.","journal-title":"Eur J Heart Fail"},{"key":"BFhr201524_CR35","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1161\/01.RES.0000251668.39526.c7","volume":"99","author":"A Nohria","year":"2006","unstructured":"Nohria A, Grunert ME, Rikitake Y, Noma K, Prsic A, Ganz P, Liao JK, Creager MA . Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease. Circ Res 2006; 99: 1426\u20131432.","journal-title":"Circ Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr201524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201524","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:15:23Z","timestamp":1684430123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,5]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["BFhr201524"],"URL":"https:\/\/doi.org\/10.1038\/hr.2015.24","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,5]]},"assertion":[{"value":"11 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}